The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers

With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, the Centers for Disease Control and Prevention (CDC) authorized the third dose of the Pfizer-BioNTech (BNT162b2) vaccine with the rationale for prolonged elevation of anti-SARS-CoV-2 antibody titers and prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Khuc, Thao A, Pequeno, Gregery, Betancourt-Garcia, Monica, Casciato, Adrienne M, Gomez-Martinez, Marissa, Arroyo, Carlos D, Pope, Bill D, Narmala, Shravan, Rao, Sohail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413993/
https://www.ncbi.nlm.nih.gov/pubmed/37575726
http://dx.doi.org/10.7759/cureus.41696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413993/
https://www.ncbi.nlm.nih.gov/pubmed/37575726
http://dx.doi.org/10.7759/cureus.41696

Ejemplares similares